Immunotherapy of human cancers using gene modified T lymphocytes

Juan F. Vera; Malcolm K. Brenner; Gianpietro Dotti

doi:10.2174/156652309789753338

Immunotherapy of human cancers using gene modified T lymphocytes

Juan F. Vera, Malcolm K. Brenner, Gianpietro Dotti

Houston Methodist

Research output: Contribution to journal › Review article › peer-review

26 Scopus citations

Abstract

Adoptive T cell therapies can produce objective clinical responses in patients with hematologic and solid malignancies. Genetic manipulation of T lymphocytes has been proposed as a means of increasing the potency and range of this anti-tumor activity. We now review how coupling expression of transgenic receptors with countermeasures against potent tumor immune evasion strategies is proving highly effective in pre-clinical models and describe how these approaches are being evaluated in human subjects.

Original language	English (US)
Pages (from-to)	396-408
Number of pages	13
Journal	Current Gene Therapy
Volume	9
Issue number	5
DOIs	https://doi.org/10.2174/156652309789753338
State	Published - 2009

ASJC Scopus subject areas

Molecular Medicine
Molecular Biology
Genetics
Drug Discovery
Genetics(clinical)

Access to Document

10.2174/156652309789753338

Cite this

@article{37605f411efc4f9fb6368646aa783269,

title = "Immunotherapy of human cancers using gene modified T lymphocytes",

abstract = "Adoptive T cell therapies can produce objective clinical responses in patients with hematologic and solid malignancies. Genetic manipulation of T lymphocytes has been proposed as a means of increasing the potency and range of this anti-tumor activity. We now review how coupling expression of transgenic receptors with countermeasures against potent tumor immune evasion strategies is proving highly effective in pre-clinical models and describe how these approaches are being evaluated in human subjects.",

author = "Vera, {Juan F.} and Brenner, {Malcolm K.} and Gianpietro Dotti",

year = "2009",

doi = "10.2174/156652309789753338",

language = "English (US)",

volume = "9",

pages = "396--408",

journal = "Current Gene Therapy",

issn = "1566-5232",

publisher = "Bentham Science Publishers Ltd.",

number = "5",

}

TY - JOUR

T1 - Immunotherapy of human cancers using gene modified T lymphocytes

AU - Vera, Juan F.

AU - Brenner, Malcolm K.

AU - Dotti, Gianpietro

PY - 2009

Y1 - 2009

N2 - Adoptive T cell therapies can produce objective clinical responses in patients with hematologic and solid malignancies. Genetic manipulation of T lymphocytes has been proposed as a means of increasing the potency and range of this anti-tumor activity. We now review how coupling expression of transgenic receptors with countermeasures against potent tumor immune evasion strategies is proving highly effective in pre-clinical models and describe how these approaches are being evaluated in human subjects.

AB - Adoptive T cell therapies can produce objective clinical responses in patients with hematologic and solid malignancies. Genetic manipulation of T lymphocytes has been proposed as a means of increasing the potency and range of this anti-tumor activity. We now review how coupling expression of transgenic receptors with countermeasures against potent tumor immune evasion strategies is proving highly effective in pre-clinical models and describe how these approaches are being evaluated in human subjects.

UR - http://www.scopus.com/inward/record.url?scp=73449132930&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73449132930&partnerID=8YFLogxK

U2 - 10.2174/156652309789753338

DO - 10.2174/156652309789753338

M3 - Review article

C2 - 19860654

AN - SCOPUS:73449132930

SN - 1566-5232

VL - 9

SP - 396

EP - 408

JO - Current Gene Therapy

JF - Current Gene Therapy

IS - 5

ER -

Immunotherapy of human cancers using gene modified T lymphocytes

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this